(MC-1) Pyridoxal 5'-phosphate

Phase 3

Phase 3

Development Phase

Upcoming Catalysts

Historical Events

Regulatory Approvals

No catalyst events have been recorded for this drug yet.

Competitive Landscape

0 competitors in Coronary Artery Bypass Graft Surgery

Drug Information

Target Indication

Coronary Artery Bypass Graft Surgery

Clinical Trial

Last updated: 2/13/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science

Mechanism of action & safety profile

Developer

MCUJF

MEDICURE INC

Related Pipeline

Pyridox(am)Ine 5'-Phosphate Oxidase Deficiency

Myocardial Infarction

Coronary Artery Bypass Graft Surgery

Diabetes Mellitus Type 2